CN101389761A - 使用bmi-1使星形胶质细胞去分化成为神经干细胞 - Google Patents

使用bmi-1使星形胶质细胞去分化成为神经干细胞 Download PDF

Info

Publication number
CN101389761A
CN101389761A CNA2006800535005A CN200680053500A CN101389761A CN 101389761 A CN101389761 A CN 101389761A CN A2006800535005 A CNA2006800535005 A CN A2006800535005A CN 200680053500 A CN200680053500 A CN 200680053500A CN 101389761 A CN101389761 A CN 101389761A
Authority
CN
China
Prior art keywords
cell
bmi
neural stem
stem cell
astroglia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800535005A
Other languages
English (en)
Chinese (zh)
Inventor
刘承权
文哉喜
尹炳善
金淇东
朴圭万
刘承骏
全恩暻
金甫那
郭成植
孟萨克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eun Tak KK
Original Assignee
Eun Tak KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eun Tak KK filed Critical Eun Tak KK
Publication of CN101389761A publication Critical patent/CN101389761A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/08—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from cells of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Neurology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CNA2006800535005A 2006-02-27 2006-04-12 使用bmi-1使星形胶质细胞去分化成为神经干细胞 Pending CN101389761A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20060019018 2006-02-27
KR1020060019018 2006-02-27

Publications (1)

Publication Number Publication Date
CN101389761A true CN101389761A (zh) 2009-03-18

Family

ID=38437522

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800535005A Pending CN101389761A (zh) 2006-02-27 2006-04-12 使用bmi-1使星形胶质细胞去分化成为神经干细胞

Country Status (5)

Country Link
EP (1) EP1987148A4 (de)
JP (1) JP2009528050A (de)
KR (1) KR100844971B1 (de)
CN (1) CN101389761A (de)
WO (1) WO2007097494A1 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102242146A (zh) * 2010-05-10 2011-11-16 高丽大学校产学协力团 组合物和用其产生诱导全能干细胞的方法
CN106754728A (zh) * 2016-12-30 2017-05-31 中国人民解放军总医院 后肾间充质细胞系及其制备方法与应用
CN109674809A (zh) * 2018-12-27 2019-04-26 吉林大学 一种包括miR-124-3P的组合物及其在诱导神经元形成的药物中的应用

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8129187B2 (en) 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
PT1970446E (pt) 2005-12-13 2011-09-01 Univ Kyoto Factor de reprogramação nuclear
US9213999B2 (en) 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US9683232B2 (en) 2007-12-10 2017-06-20 Kyoto University Efficient method for nuclear reprogramming
KR101532442B1 (ko) 2007-12-10 2015-06-29 고쿠리츠 다이가쿠 호진 교토 다이가쿠 효율적인 핵 초기화 방법
EP2242838A1 (de) * 2007-12-17 2010-10-27 GliaMed, Inc. Stammzellen-ähnliche zellen und verfahren zur umprogrammierung adulter somatischer säugerzellen
KR101661940B1 (ko) 2008-05-02 2016-10-04 고쿠리츠 다이가쿠 호진 교토 다이가쿠 핵 초기화 방법
KR101874463B1 (ko) 2009-10-31 2018-08-02 뉴 월드 레보러토리즈 인코포레이티드. 세포의 재프로그램화 방법 및 이의 용도
US9453205B2 (en) 2009-10-31 2016-09-27 Genesis Technologies Limited Methods for reprogramming cells and uses thereof
JP2011135864A (ja) 2009-12-30 2011-07-14 Korea Univ Research & Business Foundation Ｏｃｔ４及びＢｍｉ１、またはその上位調節子を用いて体細胞から胚幹細胞類似細胞への逆分化を誘導する組成物及びこれを用いた胚幹細胞類似細胞の製造方法
KR101158402B1 (ko) * 2009-12-30 2012-06-22 주식회사 일진케이제이 Ｂｍｉ１ 및 Ｏｃｔ４를 이용하여 체세포로부터 배아줄기세포 유사세포로의 역분화를 유도하는 조성물 및 이를 이용한 배아줄기세포 유사세포의 제조방법
EP2569420B1 (de) 2010-05-13 2018-09-05 The Regents of The University of California Verfahren und zusammensetzung zur induzierung pluripotenter menschlicher stammzellen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19516776A1 (de) * 1995-05-10 1996-11-14 Boehringer Ingelheim Int Chromatin-Regulatorgene
US6897061B1 (en) * 2000-06-16 2005-05-24 Spinal Cord Society Transdifferentiation of glial cells
US6919204B2 (en) * 2000-09-29 2005-07-19 Sangamo Biosciences, Inc. Modulation of gene expression using localization domains
JP2003033179A (ja) * 2001-07-05 2003-02-04 Asahi Kasei Corp 可逆的遺伝子導入ベクター
KR20010099203A (ko) * 2001-09-11 2001-11-09 이상훈 신경 줄기세포를 도파민성 신경세포로 분화시키는 방법

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102242146A (zh) * 2010-05-10 2011-11-16 高丽大学校产学协力团 组合物和用其产生诱导全能干细胞的方法
CN102242146B (zh) * 2010-05-10 2015-11-25 高丽大学校产学协力团 组合物和用其产生诱导全能干细胞的方法
CN106754728A (zh) * 2016-12-30 2017-05-31 中国人民解放军总医院 后肾间充质细胞系及其制备方法与应用
CN106754728B (zh) * 2016-12-30 2020-05-15 中国人民解放军总医院 后肾间充质细胞系及其制备方法与应用
CN109674809A (zh) * 2018-12-27 2019-04-26 吉林大学 一种包括miR-124-3P的组合物及其在诱导神经元形成的药物中的应用
CN109674809B (zh) * 2018-12-27 2022-08-09 吉林大学 一种包括miR-124-3P的组合物及其在诱导神经元形成的药物中的应用

Also Published As

Publication number Publication date
EP1987148A1 (de) 2008-11-05
EP1987148A4 (de) 2009-08-05
KR100844971B1 (ko) 2008-07-09
WO2007097494A1 (en) 2007-08-30
KR20070089089A (ko) 2007-08-30
JP2009528050A (ja) 2009-08-06

Similar Documents

Publication Publication Date Title
CN101389761A (zh) 使用bmi-1使星形胶质细胞去分化成为神经干细胞
US20210017494A1 (en) Methods for directed differentiation of pluripotent stem cells to immune cells
Goodwin et al. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers
Rao et al. Immortalization and controlled in vitro differentiation of murine multipotent neural crest stem cells
Pulecio et al. Conversion of human fibroblasts into monocyte-like progenitor cells
Barnett et al. In vitro and In vivo Analysis of a Rat Bipotential O–2A Progenitor Cell Line Containing the Temperature‐sensitive Mutant Gene of the SV40 Large T Antigen
Perlingeiro et al. A role for thrombopoietin in hemangioblast development
CN109182376A (zh) 分化多能性干细胞的制造方法
CN101400791A (zh) 使用nanog将星形胶质细胞去分化为神经干细胞
CN101389759A (zh) 使用Shh使星形胶质细胞去分化成为神经干细胞
Lubetzki et al. Clonal segregation of oligodendrocytes and astrocytes during in vitro differentiation of glial progenitor cells
Angel et al. Nanog overexpression allows human mesenchymal stem cells to differentiate into neural cells——Nanog transdifferentiates mesenchymal stem cells
KR20110124101A (ko) Ｂｍｉ１, ＭＥＫ 억제제와 ＧＳＫ 억제제를 이용하여 체세포로부터 배아줄기세포 유사세포로의 역분화를 유도하는 조성물 및 이를 이용한 배아줄기세포 유사세포의 제조방법
KR20110124106A (ko) Ｓｈｈ, ＦＧＦＲ 티로신 키나아제 억제제, ＭＥＫ 억제제와 ＧＳＫ 억제제를 이용하여 체세포로부터 배아줄기세포 유사세포로의 역분화를 유도하는 조성물 및 이를 이용한 배아줄기세포 유사세포의 제조방법
KR101022349B1 (ko) 중배엽간세포 혹은 ｅｓ세포, 또는 불사화한중배엽간세포로부터 신경계세포로의 분화유도 방법
KR101188878B1 (ko) 퍼모파민 및 Ｏｃｔ４를 이용하여 체세포로부터 배아줄기세포 유사세포로의 역분화를 유도하는 조성물 및 이를 이용한 배아줄기세포 유사세포의 제조방법
WO2021095811A1 (ja) 体細胞の直接分化転換方法
KR101158402B1 (ko) Ｂｍｉ１ 및 Ｏｃｔ４를 이용하여 체세포로부터 배아줄기세포 유사세포로의 역분화를 유도하는 조성물 및 이를 이용한 배아줄기세포 유사세포의 제조방법
KR20110124102A (ko) Ｂｍｉ１, Ｇ９ａＨＭＴａｓｅ 억제제와 ＤＭＮＴ 억제제를 이용하여 체세포로부터 배아줄기세포 유사세포로의 역분화를 유도하는 조성물 및 이를 이용한 배아줄기세포 유사세포의 제조방법
Dalby et al. Amanda Evans, James Baye, 2 Ernest Turro, Thomas Moreau, Marloes R. Tijssen, and Cedric Ghevaert
Coleman Determination of the Myogenic Potential of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells
Douay Perspectives in Transfusion Medicine for the Ex Vivo Control of Hematopoiesis
Yeoh et al. Effects of fibroblast growth factor overexpression and cellular localization on hematopoietic stem cell function
KR20110078224A (ko) 옥시스테롤 및 Ｏｃｔ４를 이용하여 체세포로부터 배아줄기세포 유사세포로의 역분화를 유도하는 조성물 및 이를 이용한 배아줄기세포 유사세포의 제조방법
KR20110078222A (ko) Ｓｈｈ 및 Ｏｃｔ４를 이용하여 체세포로부터 배아줄기세포 유사세포로의 역분화를 유도하는 조성물 및 이를 이용한 배아줄기세포 유사세포의 제조방법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090318